Bamboo Therapeutics closes $49.5mm Series A round; Pfizer takes equity stake
Executive Summary
Bamboo Therapeutics Inc. (gene therapies focused on orphan neurological diseases) completed a $49.5mm Series A round with participation from Pfizer Inc., CureDuchenne Ventures, and four other undisclosed investors. Pfizer contributed $43mm for a 22% equity stake in Bamboo.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice